| Primary |
| Chest Pain |
30.3% |
| Angina Pectoris |
20.8% |
| Hypertension |
11.0% |
| Cardiac Disorder |
7.0% |
| Diabetes Mellitus |
5.0% |
| Blood Cholesterol Increased |
3.3% |
| Blood Pressure Abnormal |
3.0% |
| Myocardial Infarction |
3.0% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Blood Cholesterol Abnormal |
1.8% |
| Atrial Fibrillation |
1.5% |
| Dyspnoea |
1.5% |
| Anticoagulant Therapy |
1.3% |
| Blood Pressure High |
1.3% |
| Arthritis |
1.0% |
| Chest Discomfort |
1.0% |
| Hypersensitivity |
1.0% |
| Peripheral Nerve Injury |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Drug Ineffective |
45.2% |
| Product Solubility Abnormal |
8.3% |
| Headache |
6.0% |
| Paraesthesia Oral |
5.5% |
| Chest Pain |
3.7% |
| Myocardial Infarction |
3.7% |
| Product Quality Issue |
3.2% |
| Product Taste Abnormal |
3.2% |
| Death |
2.3% |
| Glossodynia |
2.3% |
| Off Label Use |
2.3% |
| Angina Pectoris |
1.8% |
| Drug Effect Decreased |
1.8% |
| Incorrect Dose Administered |
1.8% |
| Oral Discomfort |
1.8% |
| Paraesthesia |
1.8% |
| Poor Quality Drug Administered |
1.8% |
| Hypertension |
1.4% |
| Blindness |
0.9% |
| Blood Glucose Increased |
0.9% |
|
| Secondary |
| Chest Pain |
16.6% |
| Cardiac Disorder |
11.6% |
| Hypertension |
9.3% |
| Product Used For Unknown Indication |
7.3% |
| Diabetes Mellitus |
6.7% |
| Crohn's Disease |
6.0% |
| Convulsion |
4.6% |
| Blood Cholesterol Increased |
4.3% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Angina Pectoris |
3.7% |
| Muscle Spasms |
3.0% |
| Neuropathy Peripheral |
3.0% |
| Insomnia |
2.9% |
| Myocardial Infarction |
2.9% |
| Diuretic Therapy |
2.7% |
| Migraine |
2.7% |
| Lung Disorder |
2.3% |
| Depression |
2.2% |
| Dyspnoea |
2.0% |
| Pain |
1.9% |
|
| Drug Ineffective |
18.9% |
| Chest Pain |
8.2% |
| Emphysema |
8.2% |
| Myocardial Infarction |
7.4% |
| Death |
6.6% |
| Amnesia |
4.9% |
| Headache |
4.9% |
| Adverse Reaction |
4.1% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Off Label Use |
4.1% |
| Bedridden |
3.3% |
| Diabetes Mellitus |
3.3% |
| Drug Effect Decreased |
3.3% |
| Fluid Retention |
3.3% |
| Weight Decreased |
3.3% |
| Weight Increased |
3.3% |
| Confusional State |
2.5% |
| Hypertension |
2.5% |
| Product Solubility Abnormal |
2.5% |
| Arterial Occlusive Disease |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.8% |
| Drug Use For Unknown Indication |
17.1% |
| Hypertension |
5.7% |
| Pain |
5.2% |
| Chest Pain |
4.4% |
| Cardiac Disorder |
3.6% |
| Depression |
2.9% |
| Diabetes Mellitus |
2.6% |
| Angina Pectoris |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.2% |
| Blood Cholesterol Increased |
1.9% |
| Arthritis |
1.8% |
| Coronary Artery Disease |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Atrial Fibrillation |
1.5% |
| Rheumatoid Arthritis |
1.3% |
| Nausea |
1.3% |
| Sleep Disorder |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
|
| Vomiting |
15.4% |
| Myocardial Infarction |
10.6% |
| Death |
9.1% |
| Weight Decreased |
8.2% |
| Weight Increased |
7.8% |
| Type 2 Diabetes Mellitus |
5.0% |
| Pain |
4.3% |
| Nausea |
4.1% |
| Pneumonia |
3.9% |
| Renal Failure Acute |
3.7% |
| Drug Ineffective |
3.3% |
| Dyspnoea |
3.3% |
| Tremor |
3.3% |
| Wheezing |
3.0% |
| Renal Failure |
2.6% |
| Thrombocytopenia |
2.6% |
| Urticaria |
2.6% |
| Syncope |
2.4% |
| Transient Ischaemic Attack |
2.4% |
| Urinary Tract Infection |
2.4% |
|
